OPTISON™
(Perflutren Protein-Type A Microspheres Injectable Suspension, USP)
[GE Healthcare Inc.]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CLINICAL TRIALS
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
DRUG HANDLING DIRECTIONS
HOW SUPPLIED
INDICATIONS
PRECAUTIONS
WARNING: Serious Cardiopulmonary Reactions
WARNINGS
OPTISON™OPTISON™